Literature DB >> 10022636

Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients.

S Mora1, G Barera, S Beccio, M C Proverbio, G Weber, C Bianchi, G Chiumello.   

Abstract

OBJECTIVES: Osteoporosis and alterations of bone metabolism are frequent complications of celiac disease. We evaluated the impact of long-term gluten-free diet (GFD) initiated during childhood and adolescence on bone mineralization and bone metabolism.
METHODS: We studied 30 celiac patients on GFD for > or = 5 yr. The mean age at diagnosis was 11.4+/-5.0 yr, and the mean duration of GFD was 10.7+/-4.3 yr. Results were compared with those obtained in 240 healthy controls. Bone mineral density (BMD) was measured in the lumbar spine and in the whole skeleton by dual-energy x-ray absorptiometry. Serum levels of bone-specific alkaline phosphatase (BALP) and N-terminal propeptide of type I procollagen (PINP) were measured as bone formation indices, and urine levels of N-telopeptide of type I collagen (NTx) as bone resorption index.
RESULTS: BMD measurements of celiac patients (lumbar spine: 1.131+/-0.121 g/cm2; total body: 1.145+/-0.184 g/cm2) did not differ from those of control subjects (lumbar spine: 1.131+/-0.184 g/cm2; total body: 1.159+/-0.118 g/cm2). The levels of BALP, PINP, and NTx of celiac patients did not differ from those of controls. Patients who started GFD before puberty had BMD and bone metabolism measurements comparable to those of patients who started GFD during puberty.
CONCLUSIONS: Our data show that long-term dietary treatment ensures normal mineralization and bone turnover.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10022636     DOI: 10.1111/j.1572-0241.1999.867_r.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  18 in total

Review 1.  Bone abnormalities in gastrointestinal and hepatic disease.

Authors:  F A Sylvester
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

2.  The prevalence of coeliac disease among female subjects having bone densitometry.

Authors:  C O'Leary; C Feighery; A Feighery; K Quane; F Shanahan; M Molloy; C C Cronin
Journal:  Ir J Med Sci       Date:  2002 Jul-Sep       Impact factor: 1.568

Review 3.  Evaluation and management of skeletal health in celiac disease: position statement.

Authors:  Mona A Fouda; Aliya A Khan; Muhammad Saad Sultan; Lorena P Rios; Karen McAssey; David Armstrong
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

Review 4.  Pediatric Celiac Disease: Follow-Up in the Spotlight.

Authors:  Francesco Valitutti; Chiara Maria Trovato; Monica Montuori; Salvatore Cucchiara
Journal:  Adv Nutr       Date:  2017-03-15       Impact factor: 8.701

Review 5.  Celiac disease in children and adolescents: special considerations.

Authors:  Kimberly P Newton; Shereen A Singer
Journal:  Semin Immunopathol       Date:  2012-05-02       Impact factor: 9.623

6.  The changing frequency of celiac disease diagnosed at the Stollery Children's Hospital.

Authors:  Seema Rajani; Hien Q Huynh; Justine Turner
Journal:  Can J Gastroenterol       Date:  2010-02       Impact factor: 3.522

7.  Celiac disease and pediatric type 1 diabetes: diagnostic and treatment dilemmas.

Authors:  Shama Sud; Margaret Marcon; Esther Assor; Mark R Palmert; Denis Daneman; Farid H Mahmud
Journal:  Int J Pediatr Endocrinol       Date:  2010-06-23

Review 8.  Long-term follow-up of individuals with celiac disease: an evaluation of current practice guidelines.

Authors:  Jocelyn A Silvester; Mohsin Rashid
Journal:  Can J Gastroenterol       Date:  2007-09       Impact factor: 3.522

9.  Calcium absorption and bone mineral density in celiacs after long term treatment with gluten-free diet and adequate calcium intake.

Authors:  M Pazianas; G P Butcher; J M Subhani; P J Finch; L Ang; C Collins; R P Heaney; M Zaidi; J D Maxwell
Journal:  Osteoporos Int       Date:  2004-06-17       Impact factor: 4.507

Review 10.  Bone in celiac disease.

Authors:  M-L Bianchi; M T Bardella
Journal:  Osteoporos Int       Date:  2008-04-17       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.